Phase II Global Eosinophilic Esophagitis (EoE) Study

This phase II eosinophilic esophagitis (EoE) study enrolled patients at 85 research sites across 7 countries. PatientWing contributed 23% of global enrollments by providing a tailored patient enrollment approach, collaborating closely with both research sites and participants.